Review of clinical studies of perampanel in adolescent patients

To assess the clinical trial and real‐world data for adjunctive perampanel in adolescents and develop consensus recommendations to guide the use of perampanel in this population in clinical practice.

• Publication year

  2016

• Venue

  Brain and Behavior

• Publication date

  2016-06-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/brb3.505PMID 27688936PMCID 5036429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review of clinical studies of perampanel in adolescent patients

  2016cited by this paper
• Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial

  2016influential reference
• Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study.

  2015influential reference
• Faculty Opinions recommendation of Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.

  2015influential reference
• Effectiveness and Tolerability of Perampanel in Children and Adolescents with Refractory Epilepsies: First Experiences

  2015cited by this paper
• Pharmacokinetic, Pharmacodynamic and Cognitive Effects of Adjunctive Perampanel in Adolescents With Inadequately Controlled Partial Seizures (P1.255)

  2015influential reference
• Effect of Adjunctive Perampanel on Growth and Development in Adolescents With Inadequately Controlled Partial Seizures (P1.252)

  2015cited by this paper
• Adjunctive Perampanel in Adolescents With Inadequately Controlled Partial Seizures: Efficacy and Safety Results From Study 235 (Phase II) (P7.008)

  2015influential reference
• A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria.

  2014cited by this paper
• Interim Efficacy and Safety Analysis of Adjunctive Perampanel in the Adolescent Population from the Extension Phase of 3 Double-Blind, Placebo-Controlled, Phase 3 (Core) Studies in Patients with Refractory Partial-Onset Seizures (P3.271)

  2014cited by this paper
• Evaluation of adjunctive perampanel in patients with refractory partial‐onset seizures: Results of randomized global phase III study 305

  2013influential reference
• Perampanel, a selective, noncompetitive α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial‐onset seizures: Interim results from phase III, extension study 307

  2013cited by this paper
• Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

  2013influential reference
• Adjunctive perampanel for refractory partial-onset seizures

  2012influential reference
• Randomized phase III study 306

  2012cited by this paper
• Revisiting AMPA Receptors as an Antiepileptic Drug Target

  2011influential reference
• Perampanel: A novel, orally active, noncompetitive AMPA‐receptor antagonist that reduces seizure activity in rodent models of epilepsy

  2011influential reference
• Variations in the Pattern of Pubertal Changes in Boys

  1970cited by this paper

• Role of Perampanel in the Management of Pediatric Epilepsies in Asia: Expert Opinion.

  2023cites this paper
• Real-world evaluation of perampanel effectiveness in Japanese adolescents with epilepsy

  2022cites this paper
• Preferential Antiseizure Medications in Pediatric Patients with Convulsive Status Epilepticus: A Systematic Review and Network Meta-Analysis

  2020cites this paper
• Clinical experience on the use of perampanel in epilepsy among child neurologists in the Philippines.

  2020cites this paper
• Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).

  2019cites this paper
• Real-Life Effectiveness and Tolerability of Perampanel in Pediatric Patients Aged 4 Years or Older with Epilepsy: A Korean National Multicenter Study

  2019cites this paper
• Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents

  2018cites this paper
• Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open‐label extension of phase III randomized trials: Study 307

  2018cites this paper
• Perampanel: Does it have broad‐spectrum potential?

  2018influential citation
• Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC‐611), a selective antagonist of TARP‐&ggr;8‐associated AMPA receptors

  2017cites this paper
• [New opportunities in the optimization of epilepsy treatment in adolescents].

  2017cites this paper
• ACDR Adverse Cutaneous Drug Reaction ACTH Adrenocorticotropic Hormone AED Antiepileptic Drug BCECTS Benign Childhood

  2017cites this paper
• Synaptic Changes in AMPA Receptor Subunit Expression in Cortical Parvalbumin Interneurons in the Stargazer Model of Absence Epilepsy

  2017cites this paper
• Review of clinical studies of perampanel in adolescent patients

  2016cites this paper